Di Silverio F - Search Results

1

Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

Sciarra A, Mariotti G, Gentile V, Voria G, Pastore A, Monti S, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. BJU Int. 2003 Mar;91(5):438-45. doi: 10.1046/j.1464-410x.2003.03066.x. BJU Int. 2003. PMID: 12603395 Review. No abstract available.

2

Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma.

Sciarra A, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urology. 2004 Mar;63(3):523-7. doi: 10.1016/j.urology.2003.10.043. Urology. 2004. PMID: 15028450 Clinical Trial.

3

Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases.

Sciarra A, Bosman C, Schillaci O, Monti M, Di Chiro C, Di Silverio F. Sciarra A, et al. Among authors: di silverio f, di chiro c. BJU Int. 2001 Jan;87(1):123-5. doi: 10.1046/j.1464-410x.2001.00001.x. BJU Int. 2001. PMID: 11122006 No abstract available.

4

New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.

Sciarra A, Cardi A, Dattilo C, Mariotti G, Di Monaco F, Di Silverio F. Sciarra A, et al. Among authors: di monaco f, di silverio f. Int J Clin Pract. 2006 Apr;60(4):462-70. doi: 10.1111/j.1742-1241.2006.00750.x. Int J Clin Pract. 2006. PMID: 16620361 Review.

5

Histopathological aspects associated with the diagnosis of benign prostatic hyperplasia: clinical implications.

Sciarra A, Voria G, Mariotti G, Gentile V, Pastore A, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urol Int. 2002;69(4):253-62. doi: 10.1159/000066128. Urol Int. 2002. PMID: 12444279 Review. No abstract available.

6

Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis.

Di Silverio F, Gentile V, De Matteis A, Mariotti G, Giuseppe V, Luigi PA, Sciarra A. Di Silverio F, et al. Eur Urol. 2003 Feb;43(2):164-75. doi: 10.1016/s0302-2838(02)00548-1. Eur Urol. 2003. PMID: 12565775

7

Role of radical retropubic prostatectomy in patients with locally advanced prostate cancer: the influence of Gleason score 8-10.

Sciarra A, Gentile V, Voria G, Mariotti G, Seccareccia F, Pastore A, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Urol Int. 2003;70(3):186-94. doi: 10.1159/000068777. Urol Int. 2003. PMID: 12660455

8

Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.

Sciarra A, Monti S, Gentile V, Mariotti G, Cardi A, Voria G, Lucera R, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Prostate. 2003 May 15;55(3):168-79. doi: 10.1002/pros.10222. Prostate. 2003. PMID: 12692782 Clinical Trial.

9

Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancer.

Di Silverio F, Sciarra A. Di Silverio F, et al. J Urol. 2003 Nov;170(5):1812-6. doi: 10.1097/01.ju.0000092480.71873.26. J Urol. 2003. PMID: 14532782

10

Histopathological aspects of transitional cell carcinoma of the bladder: analysis of 20 years experience.

Sciarra A, De Matteis A, Mariotti G, Voria G, Lucera R, Di Silverio F. Sciarra A, et al. Among authors: di silverio f. Int J Urol. 2004 Jul;11(7):467-75. doi: 10.1111/j.1442-2042.2004.00834.x. Int J Urol. 2004. PMID: 15242354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters